The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

OraSure Technologies Inc

Nasdaq: OSUR
Last

(U.S.) $15.76

Today's change+0.21 +1.35%
Updated June 26 2:04 PM EDT. Delayed by at least 15 minutes.
 

OraSure Technologies Inc

Nasdaq: OSUR
Last

(U.S.) $15.76

Today's change+0.21 +1.35%
Updated June 26 2:04 PM EDT. Delayed by at least 15 minutes.

OraSure Technologies Inc up (U.S.)$0.21

OraSure Technologies Inc is up today by (U.S.)$0.21 or 1.35% to (U.S.)$15.76. Over the last five days, shares have gained 5.49% and 79.50% year to date. Shares have outperformed the S&P 500 by 118.56% during the last year.

Key company metrics

  • Open(U.S.) $15.56
  • Previous close(U.S.) $15.55
  • High(U.S.) $15.84
  • Low(U.S.) $15.46
  • Bid / Ask(U.S.) $15.75 / (U.S.) $15.76
  • YTD % change+79.50%
  • Volume289,954
  • Average volume (10-day)568,668
  • Average volume (1-month)626,064
  • Average volume (3-month)923,688
  • 52-week range(U.S.) $5.57 to (U.S.) $15.90
  • Beta1.57
  • Trailing P/E30.54×
  • P/E 1 year forward37.20×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.52
Updated June 26 2:04 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+22.57%

Based on its net profit margin of 22.57%, OraSure Technologies Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.06%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue33353231
Total other revenue--------
Total revenue33353231
Gross profit20242321
Total cost of revenue12121010
Total operating expense17282627
Selling / general / administrative14161314
Research & development3133
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)-130----
Other operating expenses, total--------
Operating income16764
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax16774
Income after tax12764
Income tax, total4000
Net income12764
Total adjustments to net income--------
Net income before extra. items12764
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items12764
Inc. avail. to common incl. extra. items12764
Diluted net income12764
Dilution adjustment--------
Diluted weighted average shares59575756
Diluted EPS excluding extraordinary itemsvalue per share0.210.130.110.07
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.050.130.110.07